Metropolitan Life Insurance Company (MetLife)’s Axon Enterprise AXON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,841
| Closed | -$889K | – | 231 |
|
|
2024
Q1 | $889K | Sell |
2,841
-27
| -0.9% | -$7.5K | 0.04% | 358 |
|
|
2023
Q4 | $741K | Sell |
2,868
-40
| -1% | -$9.01K | 0.03% | 379 |
|
|
2023
Q3 | $579K | Sell |
2,908
-150
| -5% | -$29.5K | 0.03% | 414 |
|
|
2023
Q2 | $597K | Buy |
+3,058
| New | +$633K | 0.03% | 426 |
|
|
2022
Q1 | – | Sell |
-14,757
| Closed | -$2.32M | – | 2282 |
|
|
2021
Q4 | $2.32M | Sell |
14,757
-278
| -2% | -$46.7K | 0.03% | 453 |
|
|
2021
Q3 | $2.63M | Sell |
15,035
-274
| -2% | -$49.8K | 0.04% | 382 |
|
|
2021
Q2 | $2.71M | Sell |
15,309
-8
| -0.1% | -$1.18K | 0.04% | 393 |
|
|
2021
Q1 | $2.18M | Buy |
15,317
+407
| +3% | +$63.4K | 0.03% | 483 |
|
|
2020
Q4 | $1.83M | Sell |
14,910
-346
| -2% | -$39.7K | 0.03% | 519 |
|
|
2020
Q3 | $1.38M | Sell |
15,256
-564
| -4% | -$49.1K | 0.02% | 576 |
|
|
2020
Q2 | $1.55M | Sell |
15,820
-16,003
| -50% | -$1.29M | 0.03% | 507 |
|
|
2020
Q1 | $2.25M | Sell |
31,823
-1,203
| -4% | -$90.1K | 0.05% | 341 |
|
|
2019
Q4 | $2.42M | Sell |
33,026
-397
| -1% | -$25.1K | 0.04% | 442 |
|
|
2019
Q3 | $1.9M | Buy |
33,423
+15,074
| +82% | +$951K | 0.03% | 527 |
|
|
2019
Q2 | $1.18M | Buy |
18,349
+114
| +0.6% | +$7.43K | 0.02% | 807 |
|
|
2019
Q1 | $992K | Sell |
18,235
-300
| -2% | -$15.4K | 0.02% | 881 |
|
|
2018
Q4 | $811K | Buy |
18,535
+267
| +1% | +$13.9K | 0.02% | 920 |
|
|
2018
Q3 | $1.25M | Buy |
18,268
+1,402
| +8% | +$94.6K | 0.02% | 805 |
|
|
2018
Q2 | $1.07M | Sell |
16,866
-14,854
| -47% | -$804K | 0.02% | 885 |
|
|
2018
Q1 | $1.25M | Buy |
31,720
+14,819
| +88% | +$462K | 0.02% | 796 |
|
|
2017
Q4 | $448K | Sell |
16,901
-20,345
| -55% | -$489K | 0.01% | 1363 |
|
|
2017
Q3 | $844K | Hold |
37,246
| – | – | 0.01% | 1355 |
|
|
2017
Q2 | $936K | Buy |
37,246
+594
| +2% | +$14.5K | 0.01% | 1281 |
|
|
2017
Q1 | $835K | Sell |
36,652
-1,125
| -3% | -$27.6K | 0.01% | 1326 |
|
|
2016
Q4 | $916K | Hold |
37,777
| – | – | 0.01% | 1343 |
|
|
2016
Q3 | $1.08M | Hold |
37,777
| – | – | 0.01% | 1239 |
|
|
2016
Q2 | $940K | Hold |
37,777
| – | – | 0.01% | 1291 |
|
|
2016
Q1 | $742K | Hold |
37,777
| – | – | 0.01% | 1333 |
|
|
2015
Q4 | $653K | Sell |
37,777
-1,270
| -3% | -$25.4K | 0.01% | 1453 |
|
|
2015
Q3 | $860K | Hold |
39,047
| – | – | 0.01% | 1276 |
|
|
2015
Q2 | $1.3M | Sell |
39,047
-2,866
| -7% | -$89.6K | 0.01% | 1136 |
|
|
2015
Q1 | $1.01M | Sell |
41,913
-410
| -1% | -$10.4K | 0.01% | 1185 |
|
|
2014
Q4 | $1.12M | Buy |
42,323
+1,659
| +4% | +$32.7K | 0.01% | 1264 |
|
|
2014
Q3 | $628K | Hold |
40,664
| – | – | ﹤0.01% | 1572 |
|
|
2014
Q2 | $541K | Sell |
40,664
-78
| -0.2% | -$1.16K | ﹤0.01% | 1775 |
|
|
2014
Q1 | $745K | Hold |
40,742
| – | – | 0.01% | 1547 |
|
|
2013
Q4 | $647K | Hold |
40,742
| – | – | ﹤0.01% | 1626 |
|
|
2013
Q3 | $607K | Buy |
40,742
+4,321
| +12% | +$46.4K | ﹤0.01% | 1620 |
|
|
2013
Q2 | $310K | Buy |
+36,421
| New | +$318K | ﹤0.01% | 2021 |
|
Other funds holding AXON
Metropolitan Life Insurance Company (MetLife)'s AXON Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Axon Enterprise (AXON) in Q2 2024, closing a stake of 2,841 shares — an estimated $889K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in AXON in Q2 2013 and held it in 39 quarters. The position peaked at $2.71M in Q2 2021. 763 funds tracked by Wall St. Rank hold AXON as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Axon Enterprise position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 2,841 Axon Enterprise shares in Q2 2024, an estimated $889K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Axon Enterprise in Q2 2013 and held it in 39 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Axon Enterprise position peaked at $2.71M in Q2 2021.
- 763 funds tracked by Wall St. Rank held Axon Enterprise as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.